Lingli Wang
Impact in
-
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Antibiotic Resistance in Bacteria 7
- Co-authors
- Marlene RabinovitchVinicio A. de Jesús PérezAiqin CaoTero‐Pekka AlastaloTakashi UrashimaGeorg HansmannChristophe GuignabertJan K. Hennigs
- Journals
- Circulation Research (7 papers)Circulation (5 papers)Journal of Antimicrobial Chemotherapy (4 papers)Journal of Ethnopharmacology (3 papers)Scientific Reports (3 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Lingli Wang
175 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 146
- Pulmonary and Respiratory Medicine 2.0k
- Cancer Research 714
- Aging 65
- Cardiology and Cardiovascular Medicine 767
- Molecular Biology 2.1k
Countries citing papers authored by Lingli Wang
This map shows the geographic impact of Lingli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingli Wang more than expected).
Fields of papers citing papers by Lingli Wang
This network shows the impact of papers produced by Lingli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingli Wang. The network helps show where Lingli Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingli Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 25 | |
| 8 | 2023 | 22 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 44 | |
| 11 | 2022 | 1 | |
| 12 | 2021 | 32 | |
| 13 | 2021 | 26 | |
| 14 | 2020 | 5 | |
| 15 | 2018 | 3 | |
| 16 | Optimization of L-ascorbate oleate production using response surface methodology and its properties | 2016 | 1 |
| 17 | [Characterization of Aldoses in Edible Bird's Nest from Southeast Asia by Gas Chromatography]. | 2015 | 1 |
| 18 | Effects of penehyclidine hydrochloride on apoptosis of lung tissues in rats with traumatic acute lung injury. | 2010 | 13 |
| 19 | 2009 | 70 | |
| 20 | 2008 | 47 |
About Lingli Wang
Lingli Wang is a scholar working on Horticulture, Molecular Medicine, Complementary and alternative medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 184 papers that have together received 4.9k indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (30 papers), Metabolomics and Mass Spectrometry Studies (8 papers), RNA modifications and cancer (8 papers), MicroRNA in disease regulation (8 papers), Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Circular RNAs in diseases (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.0k citations), Cancer Research (714 citations), Aging (65 citations), Cardiology and Cardiovascular Medicine (767 citations) and Molecular Biology (2.1k citations). Lingli Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Marlene Rabinovitch, Vinicio A. de Jesús Pérez, Aiqin Cao, Tero‐Pekka Alastalo, Takashi Urashima, Georg Hansmann, Christophe Guignabert, Jan K. Hennigs, Julian P. T. Higgins and James D. Brooks. Their work appears in journals such as Circulation Research, Circulation, Journal of Antimicrobial Chemotherapy, Journal of Ethnopharmacology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.